|Bid||7,361.00 x 0|
|Ask||7,410.00 x 0|
|Day's range||7,112.00 - 7,563.50|
|52-week range||4,481.00 - 7,563.50|
|Beta (5Y monthly)||0.74|
|PE ratio (TTM)||157.61|
|Forward dividend & yield||87.31 (1.18%)|
|Ex-dividend date||18 Feb 2022|
|1y target est||N/A|
Dr. Owais Durrani, Emergency Medicine Physician, joins Yahoo Finance Live to discuss including the booster shot in definitions of being fully vaccinated, monitoring and testing for potential COVID symptoms, transmissibility in hospitals for non-COVID patients, and the outlook on variant case numbers.
Yahoo Finance's Adriana Belmonte details several of the reasons why people are opting not to receive their booster shot, from believing the Omicron variant is only mild symptoms to the political climate around vaccines.
Few companies can remain in business for more than 100 years, and the ability to do so says a lot about a corporation. Of course, past performance isn't a guarantee of future success, but for investors seeking "forever stocks," it might be worth considering those companies that have already stood the test of time. Let's look at two healthcare giants that have been around for over 100 years and will likely remain in business for much longer: Johnson & Johnson (NYSE: JNJ) and Eli Lilly (NYSE: LLY).